As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Metagenomi, Inc. (NASDAQ: MGX) pursuant and/or traceable to the Company's initial public offering conducted between ...

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

A coroner has said she could not ‘contemplate the grief’ experienced by the parents of a young woman who died after a routine medical procedure – eight years after their son died in the Shoreham ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...